Biotech Catalyst In May


01-May-2018 16:23 PM



    The start of the new month for new opportunity to trade and invest. For the biotech enthusiast, May is a month full of catalyst events to be on the lookout. There are multiples  FDA Prescription Drug User Fee Act (PDUFA) dates, Advisory Committee (Adcom) dates, and multiples biotech Phase 2 and 3 data. 

PDUFA dates:

  1. Seattle Genetics Inc (SGEN)- May 1st
  2. Portola Pharmaceuticals Inc (PTLA)- May 4
  3. Dova Pharmaceuticals Inc (DOVA)- May 21
  4. Recro Pharma Inc (REPH)- May 26
  5. Amgen Inc (AMGN)- May 28
  6. TherapeuticsMD Inc (TXMD) May 29

Adcom dates:

  1. Achaogen Inc (AKAO)- May 2
  2. Lipcine Inc (LPCN)- May 8
  3. Akcea Therapeutics Inc and Ionis Pharmaceuticals (IONS)- May 10
  4. INSYS Therapeutics Inc (INSY)- May 22.

For more info, see our Calendar events

   In addition, there are multiples biotech Phase 2 and 3 data to be in May or later this Q2. Here are some ideas:

  1. Aveo Pharmaceuticals Inc (AVEO)- Phase 3 TIVO-3
  2. Cara Therapeutics Inc (CARA) - Phase 3 CR845
  3. CTi Biopharma Corp (CTIC)- Phase 3
  4. Global Blood Therapeutics Inc (GBT)- Phase 2 
  5. Nabriva Therapeutics PLC (NBRV). Phase 3
  6. Strongbridge Biopharma Plc (SBBP)(Phase 3

    For a complete list of Q2 biotech data, see our link tab

   To help investors with biotech data results, our #BiotechCalculator has 83% right on predicting data results. You can sign up to our site and try it out. Here is the blog for, "Biotech Upcoming Data and #BiotechCalculator Success"

   An example how to input data into the #BiotechCalculator. Global Blood Therapeutics Inc (GBT) Phase 2 to be out this month or this quarter. 

Ticker: GBT

Phase: 2

Disease Area:  Hematology

Market Cap:  $1 billion- above

Speculation from our unique statistics formula that this data will be positive.

To use Biotech Success Speculation Probability

   All things considered, these are ideas and opinion only. You must do your own due diligence. The stock market is risky in general and biotech sector is at the top of high risk. Always know what you own. Thanks for reading, best of luck.

Contact us:

Twitter: @BiotechMoney18




Add Your Comment

Please select phase first
Disclaimer! This is NOT an investment advice. The data result herein is purely speculation only. You must do your own due diligence and mitigate your risk. You acknowledge that will not be held responsible and accountable for any losses you may incur using our Biotech Data Calculator. Please consult your own financial adviser before executing trades.